Literature DB >> 30054825

The Distal Predilection of Small Bowel Neuroendocrine Tumors.

Kendall J Keck1, Jessica E Maxwell1, Alan F Utria1, Andrew M Bellizzi2, Joseph S Dillon3, Thomas M O'Dorisio3, James R Howe4.   

Abstract

BACKGROUND: The small bowel (SB) is the most common site of neuroendocrine tumors (NETs) of the GI tract. These are described as being predominantly jejunoileal, but their exact locations within the SB have not been well defined. We sought to determine prospectively the spectrum of SBNET locations.
METHODS: Patients undergoing exploration for SBNET primaries had measurement of bowel length, tumor locations, and resection length recorded. Correlations of clinicopathologic factors were performed, and analysis done utilizing Welch's t test, Chi square test, and the Kaplan-Meier method.
RESULTS: Measurements were recorded in 123 patients, 107 of whom had complete information. Multifocal tumors (MTs) were found in 69 (56%) and unifocal (UTs) in 54 (44%) patients. Only 1 of 107 patients had a tumor within 100 cm of the ligament of Treitz (LT), whereas 77 of 107 (72%) had tumors within 100 cm of the ileocecal valve (ICV). No MTs were found within 100 cm of LT, whereas 41 of 60 (68%) patients had all (10) or at least one tumor (31) located within 100 cm of the ICV. MTs required a mean resection length of 108 versus 59 cm for UTs (p < 0.01). Seventy-seven percent of UTs (36/47) were within 100 cm of ICV. Tumors occurring only between > 100 cm from the LT and ICV were seen in 29 of 107 (27%) patients.
CONCLUSIONS: SBNETs are frequently multifocal and most commonly located within 100 cm of the ICV. SBNETs are less prevalent proximally in the small bowel, which may result from anatomic differences in enterochromaffin cell density, hormonal factors, or environmental exposures in the distal SB.

Entities:  

Mesh:

Year:  2018        PMID: 30054825      PMCID: PMC6525566          DOI: 10.1245/s10434-018-6676-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

Review 1.  Carcinoid Tumors: Past, Present, and Future.

Authors:  James R Howe
Journal:  Indian J Surg Oncol       Date:  2020-05-09

2.  Small Bowel Neuroendocrine Tumors.

Authors:  Catherine G Tran; Scott K Sherman; James R Howe
Journal:  Curr Probl Surg       Date:  2020-05-15       Impact factor: 1.909

Review 3.  Small bowel neuroendocrine neoplasm: what surgeons want to know.

Authors:  Akshya Gupta; Meghan G Lubner; Jason B Liu; Elizabeth S Richards; Perry J Pickhardt
Journal:  Abdom Radiol (NY)       Date:  2022-03-21

Review 4.  Workup of Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Joseph S Dillon
Journal:  Surg Oncol Clin N Am       Date:  2020-04       Impact factor: 3.495

Review 5.  Pathologic Considerations in Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Andrew M Bellizzi
Journal:  Surg Oncol Clin N Am       Date:  2020-04       Impact factor: 3.495

Review 6.  The Landmark Series: Management of Small Bowel Neuroendocrine Tumors.

Authors:  Catherine G Tran; Scott K Sherman; James R Howe
Journal:  Ann Surg Oncol       Date:  2021-01-15       Impact factor: 5.344

Review 7.  How to Manage Small Intestine (Jejunal and Ileal) Neuroendocrine Neoplasms Presenting with Liver Metastases?

Authors:  Bruno Niederle; Andreas Selberherr; Martin B Niederle
Journal:  Curr Oncol Rep       Date:  2021-05-20       Impact factor: 5.075

8.  Unexpected Finding of a Small Intestinal Neuroendocrine Tumor: A Case Report and Literature Review.

Authors:  Elena Patanè; Sebastian Douglas Sgardello; Boumediene Guendil; Ian Fournier; Ziad Abbassi
Journal:  Am J Case Rep       Date:  2020-01-28

9.  It Is Time to Rethink Biomarkers for Surveillance of Small Bowel Neuroendocrine Tumors.

Authors:  Catherine G Tran; Scott K Sherman; Aaron T Scott; Po Hien Ear; Chandrikha Chandrasekharan; Andrew M Bellizzi; Joseph S Dillon; Thomas M O'Dorisio; James R Howe
Journal:  Ann Surg Oncol       Date:  2020-07-11       Impact factor: 5.344

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.